Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Non-Interest Income (2016 - 2022)

Historic Non-Interest Income for BioRestorative Therapies (BRTX) over the last 12 years, with Q2 2022 value amounting to $245.0.

  • BioRestorative Therapies' Non-Interest Income fell 9606.11% to $245.0 in Q2 2022 from the same period last year, while for Mar 2023 it was $245.0, marking a year-over-year decrease of 9758.83%. This contributed to the annual value of $12290.0 for FY2021, which is 5654.33% down from last year.
  • BioRestorative Therapies' Non-Interest Income amounted to $245.0 in Q2 2022, which was down 9606.11% from $469.0 recorded in Q1 2022.
  • In the past 5 years, BioRestorative Therapies' Non-Interest Income registered a high of $156179.0 during Q3 2019, and its lowest value of $150.0 during Q3 2020.
  • Its 5-year average for Non-Interest Income is $42147.1, with a median of $11028.5 in 2019.
  • Its Non-Interest Income has fluctuated over the past 5 years, first surged by 212039.21% in 2018, then crashed by 9990.4% in 2020.
  • Quarter analysis of 5 years shows BioRestorative Therapies' Non-Interest Income stood at $138489.0 in 2018, then grew by 12.77% to $156179.0 in 2019, then crashed by 99.9% to $150.0 in 2020, then skyrocketed by 2013.33% to $3170.0 in 2021, then plummeted by 92.27% to $245.0 in 2022.
  • Its last three reported values are $245.0 in Q2 2022, $469.0 for Q1 2022, and $3170.0 during Q4 2021.